Safety and efficacy of venous Paracetamol with venous Ibubrofen in treatment of Patent ductus arteriosus (PDA) among premature Neonates Hospitalized in NICU, Zanjan Ayatollah Musavi Hospital in 2016- 2017
Phase 2
- Conditions
- Patent ductus arteriosus (PDA).Patent ductus arteriosus
- Registration Number
- IRCT2016081729404N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Neonate with 34 week age and less with PDA diagonsis by echocardiography.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PDA size. Timepoint: PDA size befor and after treatment messured with echocardiography by pediatric cardiologist. Method of measurement: According to the disease severity and echocardiography results,Patient's PDA will be examined before and after treatment by pediatric cardiologis.
- Secondary Outcome Measures
Name Time Method